Clinical Trial Update: CLR 131 Combined With Radiation for Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CLR 131 in combination with radiation for head and neck cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CLR 131

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-08-15